Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Curr Cancer Drug Targets. 2016;16(6):489–508. doi: 10.2174/1568009616666151130214646

Fig. (4).

Fig. (4).

Examples of peptide-drug conjugates that are used to target brain tumors. (a) Beliveau’s PTX-conjugated Angiopep-2 therapeutic, ANG1005. (b) c[RGDfK]-modified paclitaxel that is loaded into transferrin-bearing micelles for targeting of gliomas.